Literature DB >> 9648262

Chemoenzymatic synthesis of dendritic sialyl Lewis(x).

M M Palcic1, H Li, D Zanini, R S Bhella, R Roy.   

Abstract

Traditional structure activity relationship studies (SAR) have led to the development of numerous sialyl Lewis(x) analogs in the search for potential antiinflammatory agents. However, these methods do not take into account cluster or multivalent effects. Reported herein is the chemoenzymatic synthesis of di-, tetra-, and octa-valent sLe(x) ligands scaffolded on dendrimers. Hypervalent L-lysine cores with covalently attached 2-acetamido-2-deoxy-D-glucose (N-acetylglucosamine, GlcNAc) residues were chemically prepared and enzymatically transformed into sLe(x) containing dendrimers so that multivalency, and its role in selectin-sLe(x) interactions may be evaluated. This work constitutes another successful enzymatic synthesis of sLe(x) and represents the first example of GlcNAc elongation on a synthetic dendrimer scaffold. These sLe(x) dendrimers are currently being investigated as selectin antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9648262     DOI: 10.1016/s0008-6215(97)00263-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Donor substrate regeneration for efficient synthesis of globotetraose and isoglobotetraose.

Authors:  Jun Shao; Jianbo Zhang; Przemyslaw Kowal; Peng George Wang
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 2.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

3.  Chemical synthesis using enzymatically generated building units for construction of the human milk pentasaccharides sialyllacto-N-tetraose and sialyllacto-N-neotetraose epimer.

Authors:  Dirk Schmidt; Joachim Thiem
Journal:  Beilstein J Org Chem       Date:  2010-02-22       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.